USFDA completes inspection of SMS Lifesciences’ Kazipally facility

05 Apr 2018 Evaluate

US Food and Drug Administration (USFDA) has successfully completed its First inspection of SMS Lifesciences’ manufacturing facility located at Kazipally in the state of Telangana. The USFDA concluded the inspection with one Form 483 observation.

SMS Lifesciences India is engaged in the business of manufacturing, buying, selling, offering consultancy, importing and exporting, acting as commission agents and generally dealing with of all types of Organic & Inorganic Chemicals, Pharmaceuticals, Active Pharmaceutical Ingredients (API) and Intermediates.

SMS Lifesciences Share Price

767.40 -5.40 (-0.70%)
31-May-2024 16:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1462.50
Dr. Reddys Lab 5784.50
Cipla 1451.25
Zydus Lifesciences 1001.15
Lupin 1587.90
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.